268 related articles for article (PubMed ID: 26982677)
1. Three-dimensional Radiologic Assessment of Chemotherapy Response in Ewing Sarcoma Can Be Used to Predict Clinical Outcome.
Aghighi M; Boe J; Rosenberg J; Von Eyben R; Gawande RS; Petit P; Sethi TK; Sharib J; Marina NM; DuBois SG; Daldrup-Link HE
Radiology; 2016 Sep; 280(3):905-15. PubMed ID: 26982677
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric MRI with diffusion-weighted imaging in predicting response to chemotherapy in cases of osteosarcoma and Ewing's sarcoma.
Saleh MM; Abdelrahman TM; Madney Y; Mohamed G; Shokry AM; Moustafa AF
Br J Radiol; 2020 Nov; 93(1115):20200257. PubMed ID: 32706980
[TBL] [Abstract][Full Text] [Related]
3. Pediatric Rhabdomyosarcomas: Three-Dimensional Radiological Assessments after Induction Chemotherapy Predict Survival Better than One-Dimensional and Two-Dimensional Measurements.
Orsatti G; Morosi C; Giraudo C; Varotto A; Crimì F; Bonzini M; Minotti M; Frigo AC; Zanetti I; Chiaravalli S; Casanova M; Ferrari A; Bisogno G; Stramare R
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33348683
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection.
Pan HY; Morani A; Wang WL; Hess KR; Paulino AC; Ludwig JA; Lin PP; Daw NC; Mahajan A
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):349-57. PubMed ID: 25772182
[TBL] [Abstract][Full Text] [Related]
5. Primary tumor volume measurements in Ewing sarcoma: MRI inter- and intraobserver variability and comparison with FDG-PET.
Kasalak Ö; Overbosch J; Glaudemans AWJM; Boellaard R; Jutte PC; Kwee TC
Acta Oncol; 2018 Apr; 57(4):534-540. PubMed ID: 29117758
[TBL] [Abstract][Full Text] [Related]
6. Which evaluation criteria of the short-term efficacy can better reflect the long-term outcomes for patients with nasopharyngeal carcinoma?
Ma LQ; Wu HX; Kong XQ; Fei ZD; Fang WN; Du KX; Chen F; Zhao D; Wu ZP
Transl Oncol; 2022 Jun; 20():101412. PubMed ID: 35395603
[TBL] [Abstract][Full Text] [Related]
7. Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma.
Raciborska A; Bilska K; Drabko K; Michalak E; Chaber R; Pogorzała M; Połczyńska K; Sobol G; Wieczorek M; Muszyńska-Rosłan K; Rychlowska-Pruszyńska M; Rodriguez-Galindo C; Dziuk M
Clin Transl Oncol; 2016 Feb; 18(2):189-95. PubMed ID: 26250765
[TBL] [Abstract][Full Text] [Related]
8. Unresectable Intrahepatic Cholangiocarcinoma: Multiparametric MR Imaging to Predict Patient Survival.
Pandey A; Pandey P; Aliyari Ghasabeh M; Najmi Varzaneh F; Shao N; Khoshpouri P; Zarghampour M; Fouladi DF; Liddell R; Kamel IR
Radiology; 2018 Jul; 288(1):109-117. PubMed ID: 29584595
[TBL] [Abstract][Full Text] [Related]
9. Comparison of one-, two-, and three-dimensional measurements of childhood brain tumors.
Warren KE; Patronas N; Aikin AA; Albert PS; Balis FM
J Natl Cancer Inst; 2001 Sep; 93(18):1401-5. PubMed ID: 11562391
[TBL] [Abstract][Full Text] [Related]
10. Radiologic Response Assessment in Pediatric Soft Tissue Sarcoma: Computed-Assisted Volume Evaluation.
Orsatti G; Beltrame V; Crimì F; Frigo AC; Bisogno G; Stramare R
J Pediatr; 2017 Mar; 182():327-334.e2. PubMed ID: 27939125
[TBL] [Abstract][Full Text] [Related]
11. Single and multidimensional measurements underestimate neuroblastoma response to therapy.
Trout AT; Towbin AJ; Klingbeil L; Weiss BD; von Allmen D
Pediatr Blood Cancer; 2017 Jan; 64(1):18-24. PubMed ID: 27440309
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach.
Tacher V; Lin M; Duran R; Yarmohammadi H; Lee H; Chapiro J; Chao M; Wang Z; Frangakis C; Sohn JH; Maltenfort MG; Pawlik T; Geschwind JF
Radiology; 2016 Jan; 278(1):275-84. PubMed ID: 26131913
[TBL] [Abstract][Full Text] [Related]
13. Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?
Sahu S; Schernthaner R; Ardon R; Chapiro J; Zhao Y; Sohn JH; Fleckenstein F; Lin M; Geschwind JF; Duran R
Radiology; 2017 Jun; 283(3):883-894. PubMed ID: 27831830
[TBL] [Abstract][Full Text] [Related]
14. Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods.
Galanis E; Buckner JC; Maurer MJ; Sykora R; Castillo R; Ballman KV; Erickson BJ
Neuro Oncol; 2006 Apr; 8(2):156-65. PubMed ID: 16533757
[TBL] [Abstract][Full Text] [Related]
15. Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression.
Huang RY; Unadkat P; Bi WL; George E; Preusser M; McCracken JD; Keen JR; Read WL; Olson JJ; Seystahl K; Le Rhun E; Roelcke U; Koeppen S; Furtner J; Weller M; Raizer JJ; Schiff D; Wen PY
Neuro Oncol; 2019 Feb; 21(2):234-241. PubMed ID: 30085283
[TBL] [Abstract][Full Text] [Related]
16. Quantitative diffusion-weighted magnetic resonance imaging assessment of chemotherapy treatment response of pediatric osteosarcoma and Ewing sarcoma malignant bone tumors.
Degnan AJ; Chung CY; Shah AJ
Clin Imaging; 2018; 47():9-13. PubMed ID: 28806574
[TBL] [Abstract][Full Text] [Related]
17. Response assessment in pediatric rhabdomyosarcoma: can response evaluation criteria in solid tumors replace three-dimensional volume assessments?
Schoot RA; McHugh K; van Rijn RR; Kremer LC; Chisholm JC; Caron HN; Merks JH
Radiology; 2013 Dec; 269(3):870-8. PubMed ID: 23985275
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy response is an important predictor of local recurrence in Ewing sarcoma.
Lin PP; Jaffe N; Herzog CE; Costelloe CM; Deavers MT; Kelly JS; Patel SR; Madewell JE; Lewis VO; Cannon CP; Benjamin RS; Yasko AW
Cancer; 2007 Feb; 109(3):603-11. PubMed ID: 17177205
[TBL] [Abstract][Full Text] [Related]
19. Surveillance MRI for the detection of locally recurrent Ewing sarcoma seems futile.
Kasalak Ö; Dammann A; Adams HJA; Overbosch J; Dierckx RAJO; Jutte PC; Kwee TC
Skeletal Radiol; 2018 Nov; 47(11):1517-1522. PubMed ID: 29752484
[TBL] [Abstract][Full Text] [Related]
20. MRI volume measurements compared with the RECIST 1.1 for evaluating the response to neoadjuvant chemotherapy for mass-type lesions.
An YY; Kim SH; Kang BJ; Lee AW; Song BJ
Breast Cancer; 2014 May; 21(3):316-24. PubMed ID: 22767314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
